Adrenocortical neoplasia: Evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants

Virchows Archiv

Volumn 460, Issue 1, 2012, Pages 9-18

  De Krijger, Ronald R ^a   Papathomas, Thomas G ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

ACC variants; Adenoma; Adrenal cortical neoplasia; Carcinoma; Carcinosarcoma; Myxoid; Oncocytic; Sarcomatoid

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 4; KI 67 ANTIGEN; PROTEIN P53;

ADRENAL CANCER; ADRENAL CORTEX CARCINOMA; BLASTOMA; CANCER SIZE; CARCINOGENESIS; CARCINOSARCOMA; CHROMOSOME INACTIVATION; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HISTOGENESIS; HYPERALDOSTERONISM; NEPHROBLASTOMA; ONCOCYTIC ADRENOCORTICAL NEOPLASM; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; X CHROMOSOME;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; TERMINOLOGY AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 84857059174     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1166-y     Document Type: Review

References (92)

1. Fassnacht M, Libe R, Kroiss M, Allolio B (2011) Adrenocortical carcinoma: a clinician's update. Nat Rev Endocrinol 7:323-335
2. McNicol AM (2011) Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma. Histopathology 58:155-168
3. Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757-768
4. Aubert S, Wacrenier A, Leroy X et al (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26:1612-1619 (Pubitemid 35387224)
5. Blanes A, Diaz-Cano SJ (2007) Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability. Am J Clin Pathol 127:398-408 (Pubitemid 46806333)
6. Volante M, Bollito E, Sperone P et al (2009) Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. Histopathology 55:535-543
7. Tissier F (2010) Classification of adrenal cortical tumors: what limits for the pathological approach? Best Pract Res Clin EndocrinolMetab 24:877-885
8. Dehner LP, Hill DA (2009) Adrenal cortical neoplasms in children: why so many carcinomas and yet so many survivors? Pediatr Dev Pathol 12:284-291
9. Bertherat J, Bertagna X (2009) Pathogenesis of adrenocortical cancer. Best Pract Res Clin Endocrinol Metab 23:261-271
10. GrumbachMM, Biller BM, Braunstein GD et al (2003) Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med 138:424-429 (Pubitemid 36262654)
11. Sidhu S, Marsh DJ, Theodosopoulos G et al (2002) Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab 87:3467-3474 (Pubitemid 34816405)
12. Gruschwitz T, Breza J,Wunderlich H, Junker K (2010) Improvement of histopathological classification of adrenal gland tumors by genetic differentiation. World J Urol 28:329-334
13. Kjellman M, Larsson C, Bäckdahl M (2001) Genetic background of adrenocortical tumor development. World J Surg 25:948-956 (Pubitemid 32666398)
14. Gicquel C, Leblond-Francillard M, Bertagna X et al (1994) Clonal analysis of human adrenocortical carcinomas and secreting adenomas. Clin Endocrinol (Oxf) 40:465-477 (Pubitemid 24194644)
15. Beuschlein F, Reincke M, Karl M et al (1994) Clonal composition of human adrenocortical neoplasms. Cancer Res 54:4927-4932 (Pubitemid 24289423)
16. Kjellman M, Roshani L, Teh BT et al (1999) Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J Clin Endocrinol Metab 84:730-735 (Pubitemid 29075713)
17. BernardMH, Sidhu S, Berger N et al (2003) A case report in favor of a multistep adrenocortical tumorigenesis. J Clin Endocrinol Metab 88:998-1001 (Pubitemid 36337746)
18. Trezzi R, Poli F, Fellegara G (2009) "Dedifferentiated" adrenal cortical neoplasm. Int J Surg Pathol 17:343-344
19. Gaujoux S, Tissier F, Groussin L et al (2008) Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors. J Clin Endocrinol Metab 93:4135-4140
20. Schmitt A, Saremaslani P, Schmid S et al (2006) IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 49:298-307 (Pubitemid 44253620)
21. van't Sant HP, Bouvy ND, Kazemier G et al (2007) The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas. Histopathology 51:239-245 (Pubitemid 47083991)
22. de Reyniès A, Assié G, Rickman DS et al (2009) Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol 27:1108-1115
23. Giordano TJ, Kuick R, Else T et al (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res 15:668-676
24. Laurell C, Velázquez-Fernández D, Lindsten K et al (2009) Transcriptional profiling enables molecular classification of adrenocortical tumours. Eur J Endocrinol 161:141-152
25. Ragazzon B, Libé R, Gaujoux S et al (2010) Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Res 70:8276-8281
26. Ragazzon B, Assié G, Bertherat J (2011) Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments. Endocr Relat Cancer 18:R15-R27
27. Bussey KJ,DemeureMJ (2009) Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment. Future Oncol 5:641-655
28. Bussey KJ, Demeure MJ (2011) Toward a pathway-centered approach for the treatment of adrenocortical carcinoma. Curr Opin Oncol 23:34-44
29. Martinerie C, Gicquel C, Louvel A et al (2001) Altered expression of novH is associated with human adrenocortical tumorigenesis. J Clin Endocrinol Metab 86:3929-3940 (Pubitemid 32756000)
30. Berthon A, Sahut-Barnola I, Lambert-Langlais S et al (2010) Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development. Hum Mol Genet 19:1561-1576
31. Tissier F, Cavard C, Groussin L et al (2005) Mutations of betacatenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 65:7622-7627 (Pubitemid 41297234)
32. Tadjine M, Lampron A, Ouadi L, Bourdeau I (2008) Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 68:264-270
33. Bonnet S, Gaujoux S, Launay P et al (2011) Wnt/{beta}-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and - nonsecreting tumors. J Clin Endocrinol Metab 96:E419-E426
34. Tadjine M, Lampron A, Ouadi L et al (2008) Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD). Clin Endocrinol (Oxf) 69:367-373
35. Gaujoux S, Grabar S, Fassnacht M et al (2011) β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma. Clin Cancer Res 17:328-336
36. Durand J, Lampron A, Mazzuco TL, Chapman A, Bourdeau I (2011) Characterization of differential gene expression in adrenocortical tumors harboring {beta}-catenin (CTNNB1) mutations. J Clin Endocrinol Metab 96:E1206-E1211
37. Chapman A, Durand J, Ouadi L, Bourdeau I (2011) Identification of genetic alterations of AXIN2 gene in adrenocortical tumors. J Clin Endocrinol Metab (Epub ahead of print)
38. Kakimoto S, Yushita Y, Sanefuji T et al (1986) Non-hormonal adrenocortical adenoma with oncocytoma-like appearances. Hinyokika Kiyo 32:757-763
39. Wong DD, Spagnolo DV, Bisceglia M et al (2011) Oncocytic adrenocortical neoplasms-a clinicopathologic study of 13 new cases emphasizing the importance of their recognition. Hum Pathol 42:489-499
40. Saad R, Marsault S, Coloby P (2011) Adrenocortical oncocytic cells tumor: case report and review of literature. Prog Urol 21:288-290
41. Mwandila M, Waller H, Stott V, Mercer P (2010) A case of a testosterone-secreting oncocytic adrenocortical carcinoma. N Z Med J 123:80-82
42. Rosenkrantz AB, Do RK, Hajdu CH (2010) Imaging appearance of bulk fat within an oncocytic adrenocortical neoplasm, a rare and potentially malignant tumour. Br J Radiol 83:e204-e207
43. Cham E, Watkin W, Goldschmidt R, Liu L (2010) Fine needle aspiration cytology of adrenocortical oncocytic neoplasm: a case report. Acta Cytol 54:627-634
44. Ohtake H, Kawamura H, Matsuzaki M et al (2010) Oncocytic adrenocortical carcinoma. Ann Diagn Pathol 14:204-208
45. Bisceglia M, Ben-Dor D, Pasquinelli G (2005) Oncocytic adrenocortical tumors. Pathol Case Rev 10:228-242
46. Bisceglia M, Ludovico O, Di Mattia A et al (2004) Adrenocortical oncocytic tumors: report of 10 cases and review of the literature. Int J Surg Pathol 12:231-243 (Pubitemid 39063350)
47. Willems SM, Wiweger M, van Roggen JF, Hogendoorn PC (2010) Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist? Virchows Arch 456:181-192
48. PapottiM, VolanteM, Duregon E et al (2010) Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibitingmalignant behavior. AmJ Surg Pathol 34:973-983
49. Brown FM, Gaffey TA, Wold LE, Lloyd RV (2000) Myxoid neoplasms of the adrenal cortex: a rare histologic variant. Am J Surg Pathol 24:396-401 (Pubitemid 30127475)
50. Raparia K, Ayala AG, Sienko A, Zhai QJ, Ro JY (2008) Myxoid adrenal cortical neoplasms. Ann Diagn Pathol 12:344-348
51. Dundr P, Novák K (2003) Pseudoglandular myxoid adenoma of the adrenal gland. Pathol Res Pract 199:493-496 (Pubitemid 37098809)
52. Honda K, Kashima K, Daa T et al (2001) Myxoid adrenal cortical adenoma. Pathol Int 51:887-891 (Pubitemid 34205981)
53. Jang KY, ChungMJ,MoonWS et al (2009) Adrenocortical adenoma with unusual myxoid histological pattern: a case report. Pathology 41:188-191
54. IshidaM,YoshidaK,MiyamotoKet al (2008) Cytological features of myxoid adrenocortical adenoma with a pseudoglandular component: a case report with differential diagnostic considerations. Diagn Cytopathol 36:576-580
55. Fine SW, Pindzola JA, Uhlman EJ, Epstein JI (2005) Pathologic quiz case: a 64-year-old man with an adrenal mass. Myxoid adrenal cortical neoplasm. Arch Pathol Lab Med 129:541-542 (Pubitemid 40471208)
56. De Padua M, Rajagopal V (2008) Myxoid adrenal adenoma with focal pseudoglandular pattern. Indian J Med Sci 62:199-203 (Pubitemid 351821551)
57. Zhu Y, Wu YX, Zhang CY et al (2008) Myxoid adrenocortical adenoma: a case report. Chin Med J (Engl) 121:1598-1600
58. Lu HS, Gan MF, Chen HS, Huang SQ (2008) Adrenal myelolipoma within myxoid cortical adenoma associated with Conn's syndrome. J Zhejiang Univ Sci B 9:500-505
59. Bollito ER, PapottiM, Porpiglia F et al (2004)Myxoid adrenocortical adenoma with a pseudoglandular pattern. Virchows Arch 445:414-418 (Pubitemid 39517769)
60. Tang CK, Harriman BB, Toker C (1979) Myxoid adrenal cortical carcinoma: a light and electron microscopic study. Arch Pathol Lab Med 103:635-638 (Pubitemid 10189504)
61. Forsthoefel KF (1994) Myxoid adrenal cortical carcinoma. A case report with differential diagnostic considerations. Arch Pathol Lab Med 118:1151-1153 (Pubitemid 24345845)
62. Hsieh MS, Chen JH, Lin LW (2010) Myxoid adrenal cortical carcinoma presenting as primary hyperaldosteronism: case report and review of the literature. Int J Surg Pathol (Epub ahead of print)
63. Karim RZ, Wills EJ, McCarthy SW, Scolyer RA (2006) Myxoid variant of adrenocortical carcinoma: report of a unique case. Pathol Int 56:89-94
64. Suresh B, Kishore TA, Albert AS, Joy A (2005) Myxoid adrenal cortical carcinoma-a rare variant of adrenocortical carcinoma. Indian J Med Sci 59:505-507 (Pubitemid 41809674)
65. Izumi M, Serizawa H, Iwaya K et al (2003) A case of myxoid adrenocortical carcinoma with extensive lipomatous metaplasia. Arch Pathol Lab Med 127:227-230 (Pubitemid 36231774)
66. DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon
67. SturmN,MoulaiN, LaverrièreMHet al (2008) Primary adrenocortical sarcomatoid carcinoma: case report and review of literature. Virchows Arch 452:215-219
68. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon
69. Sasaki K, Desimone M, Rao HR, Huang GJ, Seethala RR (2010) Adrenocortical carcinosarcoma: a case report and review of the literature. Diagn Pathol 5:51
70. Coli A, Di Giorgio A, Castri F (2010) Sarcomatoid carcinoma of the adrenal gland: a case report and review of literature. Pathol Res Pract 206:59-65
71. Lee MS, Park IA, Chi JG et al (1997) Adrenal carcinosarcoma-a case report. J Korean Med Sci 12:374-377 (Pubitemid 127711347)
72. Barksdale SK, Marincola FM, Jaffe G (1993) Carcinosarcoma of the adrenal cortex presenting with mineralocorticoid excess. Am J Surg Pathol 17:941-945 (Pubitemid 23245929)
73. Fischler DF, Nunez C, LevinHS et al (1992)Adrenal carcinosarcoma presenting in a woman with clinical signs of virilization. A case report with immunohistochemical and ultrastructural findings. Am J Surg Pathol 16:626-631
74. Decorato JW, Gruber H, Petti M, Levowitz BS (1990) Adrenal carcinosarcoma. J Surg Oncol 45:134-136 (Pubitemid 20353701)
75. Collina G, Maldarizzi F, Betts CM, Eusebi V (1989) Primary sarcomatoid carcinoma of the adrenal gland. First case report. Virchows Arch A Pathol Anat Histopathol 415:161-167 (Pubitemid 19170565)
76. Okazumi S, Asano T, Ryu M et al (1987) Surgical resection of adrenal carcinoma extending into the vena cava, right atrium and ventricle: case report and review of the literature. Nippon Geka Gakkai Zasshi 88:231-238
77. Weissferdt A, Moran CA (2011) Malignant biphasic tumors of the lungs. Adv Anat Pathol 18:179-189
78. Molberg K, Vuitch F, Stewart D, Albores-Saavedra J (1992) Adrenocortical blastoma. Hum Pathol 23:1187-1190
79. Lack EE (2007) Tumors of the adrenal glands and extraadrenal paraganglia-volume 8 (Afip Atlas of Tumor Pathology Series 4). American Registry of Pathology, Washington
80. Liu J, Brown RE (2010) Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp Pathol 3:755-762
81. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelialmesenchymal transitions in development and disease. Cell 139:871-890
82. Guarino M, Tricomi P, Giordano F, Cristofori E (1996) Sarcomatoid carcinomas: pathological and histopathogenetic considerations. Pathology 28:298-305 (Pubitemid 27170914)
83. Jin Z, Ogata S, Tamura G et al (2003) Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis. Int J Gynecol Pathol 22:368-373 (Pubitemid 37152987)
84. Dacic S, Finkelstein SD, Sasatomi E, Swalsky PA, Yousem SA (2002) Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol 26:510-516 (Pubitemid 34280126)
85. Thompson L, Chang B, Barsky SH (1996) Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 20:277-285 (Pubitemid 26071508)
86. Roma AA, Malpica A, Deavers MT (2011) Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature. Int J Gynecol Pathol 30:158-162
87. Liu J, Wu H (2011) Carcinosarcoma of female urethra with melanocytic differentiation. Int J Clin Exp Pathol 4:206-209
88. Amant F,Moerman P, Davel GH et al (2001) Uterine carcinosarcoma with melanocytic differentiation. Int J Gynecol Pathol 20:186-190 (Pubitemid 32239212)
89. Kajo K, Zubor P, Spacek J, Ryska A (2007) Carcinosarcoma of the uterus with melanocytic differentiation. Pathol Res Pract 203:753-758 (Pubitemid 47400192)
90. Zarineh A, Silverman JF (2011) Adrenal perivascular epithelioid cell tumor: a case report with discussion of differential diagnoses. Arch Pathol Lab Med 135:499-502
91. Sakaguchi N, Sano K, Ito M et al (1996) A case of von Recklinghausen's disease with bilateral pheochromocytomamalignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors. Am J Surg Pathol 20:889-897 (Pubitemid 26235249)
92. Gupta R, Sharma A, Arora R, Vijayaraghavan M (2009) Composite phaeochromocytoma with malignant peripheral nerve sheath tumour and rhabdomyosarcomatous differentiation in a patient without von Recklinghausen disease. J Clin Pathol 62:659-661